IONIS-TTRRx: Phase III hold

Ionis said GlaxoSmithKline will not start the Phase III CARDIO-TTR trial of IONIS-TTRRx. On a conference call, Ionis said “less than a handful” of patients receiving IONIS-TTRRx in the separate Phase III

Read the full 320 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE